Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Paediatric Drugs|December 14, 2024
How Consistent are Anti-Infective Drug Dosing Recommendations Across Three European Paediatric Formularies?Lukas Higi, Elisabeth Carydias, Andrea M Burden, et al.
European Journal of Clinical Pharmacology|September 7, 2007
Recognition and management of potential drug-drug interactions in patients on internal medicine wardsPriska Vonbach, André Dubied, Jürg H Beer, et al.
Pediatric Nephrology (Berlin, Germany)|August 12, 2015
Drugs as risk factors of acute kidney injury in critically ill childrenCorina Glanzmann, Bernhard Frey, Priska Vonbach, et al.
European Journal of Pediatrics|April 23, 2015
Analysis of medication prescribing errors in critically ill childrenCorina Glanzmann, Bernhard Frey, Christoph R Meier, et al.
European Journal of Internal Medicine|October 14, 2008
Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicinePriska Vonbach, André Dubied, Stephan Krähenbühl, et al.
Pharmacy World & Science : PWS|April 17, 2008
Evaluation of frequently used drug interaction screening programsPriska Vonbach, André Dubied, Stephan Krähenbühl, et al.
European Journal of Pediatrics|September 15, 2021
Description of a clinical decision support tool with integrated dose calculator for paediatricsLukas Higi, Karin Käser, Monika Wälti, et al.
Archives of Disease in Childhood|September 13, 2022
Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infantsMiriam Pfiffner, Verena Gotta, Marc Pfister, et al.
Frontiers in Pediatrics|March 21, 2022
Pharmacometric Analysis of Intranasal and Intravenous Nalbuphine to Optimize Pain Management in InfantsMiriam Pfiffner, Eva Berger-Olah, Priska Vonbach, et al.
BMJ Paediatrics Open|January 25, 2023
Impact of a clinical decision support system on paediatric drug dose prescribing: a randomised within-subject simulation trialLukas Higi, Raffael Schmitt, Karin Käser, et al.
Pageof 2